NKGen Biotech Korea
엔케이젠바이오텍코리아KRX: 182400· Fiscal year 2025· nkmax.com ↗
Average salary
Not disclosed
Employees
70
▼ 4.1% vs 2024
Average tenure
8.3 yrs
Reference: average annual pay in Healthcare & Pharma, South Korea: $31.4K (고용노동부 사업체노동력조사 2025 (KOSIS DT_118N_MON052), 2025). Official government wage statistics for the whole industry, not this company's pay. Definitions differ by country; see the source.
Workplace
Women's pay (men = 100)85
Women among staff62.9%
Contract staff0%
Recent official filings
- 2026-11-13Quarterly report (2026.09)
Quick read
- Headcount shrank by 3 (4.1%) from 2024.
- Revenue fell 10.7% year over year.
- Revenue has shrunk two years in a row.
- Operating loss of $1.9M in 2025.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $84.1K
- Net profit per employee
- -$78.5K
- Operating margin
- -32.2%
- Net margin
- -93.4%
- ROE
- -103.5%
- Debt-to-equity
- 101.5%
- Equity ratio
- 49.6%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.